SalesTrax.com PharmaResumeBlaster.com
Home My Account  Search Sales Jobs  Post Resumes  Recruiting Event Info  Career Resources  Post Sales Jobs 

SalesTrax.com Research: Medical / Pharma

Articles found below have been submitted through various PR and news sources and don’t necessary reflect the views of SalesTrax or its employees.
Source: Scrip World Pharmaceutical News
 Published on: 2007-06-05
11:01Pfizer files petition with Supreme Court to review Norvasc case
11:01US FDA establishes risk communication advisory panel
11:01Nexavar proclaimed new standard in liver cancer
11:01Avastin could provide new first-line option in kidney cancer
11:01Higgins sets out aims for EFPIA

 Published on: 2007-05-10
11:00IDM Pharma's mifamurtide gets negative FDA panel review for osteosarcoma
11:00Definitive deal presages Tanabe and Mitsubishi merger
11:00US Senate passes user fee and drug safety bill
11:00Pharma to be important component of EU/South Korea free trade talks
11:00Texas governor admits defeat in his effort to push mandatory Gardasil use

 Published on: 2007-05-01
10:00ECJ parallel import ruling - the last word on repackaging?
10:00GSK gets US approval for Veramyst
10:00Xenoport boost after XP13512 positive Phase III restless legs data
10:00Lifecycle seals deal with Sciele for fenofibrate
10:00Phytopharm will clinch Cogane/Myogane deal by year-end, says CEO

 Published on: 2007-04-24
11:01KKR ups its bid for Alliance Boots
11:01Vaccine business spells first-quarter success for Merck & Co
11:01Avastin to go head-to-head with Lucentis in the UK?
11:01Texas judge throws out Vioxx suit which could weaken other cases
11:01FDA to review Pharmacyclics' Xcytrin NDA

 Published on: 2007-04-16
10:01US embryonic stem cell bill faces second presidential veto
10:01Bone marrow stem cells used to free Type 1 diabetes patients from insulin use
10:01Bavarian Nordic wins US contract for smallpox vaccine stockpile
10:01Eisai pulls Europe filing for Aricept in severe Alzheimer's
10:01Merck & Co wins court dismissal of Vioxx securities fraud suit

 Published on: 2007-04-13

Source: PR Newswire
 Published on: 2009-09-24
16:00Onyx Pharmaceuticals to Host Investor Briefing Following ECCO/ESMO Oncology Congress
16:00aTyr Pharma to Present at Japan Biopharma Partnering Conference
16:00Bioniche Pharma and Synerx Pharma Launch Fomepizole Injection
16:00MediZine Named in Intellectual Property Lawsuit Filed by Marketing Technology Solutions
16:00Northern California Cancer Center Finds Increased Risk of Most Common Form of Childhood Leukemia Associated With Residential Proximity to Agricultural Pesticides
16:00Ticagrelor Reduced Cardiovascular Deaths and Heart Attacks in ACS Patients Undergoing Heart Procedures: New Data from PLATO Trial
16:00New U.K. NICE Guidance Supports Use of Hologic's Adiana(R) Permanent Contraception System
16:00Free Upcoming Program Scheduled to Help Remove Barriers To Early Cervical and Breast Cancer Diagnosis for Local Women
16:00Results from Abbott's PROSPECT Study Provide New Insight into Role of Vulnerable Plaque in Coronary Artery Disease
16:00Gersten Savage Expands IP Practice With Partner Jason Lief
16:00CAP Proposes Improved Oversight of Lab-Developed Tests
16:00Results From Landmark PROSPECT Trial Demonstrate the Ability of Volcano's VH(R) IVUS Imaging to Identify Plaques Most Likely to Cause Heart Attacks
16:00Cepheid Receives FDA Clearance for Xpert(R) HemosIL(R) FII & FV Test
16:00MedSolutions Earns Third Consecutive J.D. Power and Associates Recognition
16:00Urban Health Plan (UHP) Wins National Recognition for State-of-the-Art Electronic Health Records System
16:00Gresham Station Surgery Center Partners with Symbion Healthcare
16:00Cardica Announces Going Concern Opinion per Nasdaq Rule 5250(b)(2)
16:00UPDATE: MAQUET Cardiovascular Announces Leading Robotic Heart Surgeon Performs First Beating Heart Fully Endoscopic Bypass Surgery Using Miniaturized Cardiopulmonary Bypass System
16:00Vikas Nanda, PhD, Earns New Innovator Award from NIH - Research May Impact Treatment of Cancer, Lupus and other Autoimmune Disorders
16:00Oncolytics Biotech(R) Inc. Announces Reovirus and Cisplatin Research Supports U.S. Phase 2 Metastatic Melanoma Trial
16:00Michigan Life Science and Innovation Center Opens in Former Pfizer Facility
12:00Reportlinker Adds Worldwide Wound Care Markets: Total Coverage (Vol. I-III: Skin Ulcers, Burns, Surgical and Trauma Wounds), 4th Edition Report
12:00Reportlinker Adds Who is Who in Clinical Diagnostics in China (Manufacturers and Distributors Profiles, Market, Industry Overview) Report
12:00Reportlinker Adds World Veterinary Health Products (Animal Pharmaceuticals, Vaccines, OTC and Performance Enhancers) Report
12:00Video: Despite Increased Health Threat, New Study Finds Low Concern About Flu Among Hispanics

Source: Pharmaceutical Business Review
 Published on: 2009-09-22
12:04Varian Launches New Productivity Suite
12:04Anavex Completes Scale-up Manufacturing Of Anavex 2-73
12:04Abbott's XIENCE V Outperforms TAXUS
12:04Impax Laboratories Confirms Patent Challenge Relating To ORACEA
12:04Icagen Extends Collaboration With Pfizer
12:04ACTEGA Launches Solvent-free Adhesives Based On Renewable Raw Materials
12:04Boehringer Ingelheim Enters Into Agreement With Pfizer To Acquire Assets Of Fort Dodge Animal Health
12:04IBA, Aposense Join Forces To Commercialise Aposense [18F]-ML-10
12:04Sanofi Receives Additional Order For H1N1 Vaccine From US Government
12:04Helsinn's Palonosetron Effective In Preventing Emesis, Nausea Induced by High Dose Chemotherapy
12:04Genomic Confirms Consistent Distribution Of Oncotype DX
04:04Enzo Biochem Enters Into CRADA With National Eye Institute
04:04Valeant Provides Update On Retigabine
04:04DOR BioPharma Bags $9.4m NIH Grant
04:04Impax Pharmaceuticals Reports Results Phase II Parkinson's Trial
04:04AstraZeneca Signs Agreement For Nektar Drug Development Programmes
04:04Neuralstem Receives FDA Approval To Initiate Phase I Trial For ALS
04:04PerkinElmer Launches Columbus 2.0 Platform
04:04AssistMed Enters Into Agreement With Kerr Health Care Services
04:04Provectus Pharmaceuticals Completes Treatment Portion Of Phase 2 PV-10 Trial

 Published on: 2009-09-21
16:07Cambridge Regulatory Services Signs Strategic Alliance With SIRO Clinpharm
16:07Resolvyx Gains Chronic Dry Eye Therapy Patent
16:07Forest/Glenmark Reports Phase IIb COPD Study Results
16:07NovoStent Completes Enrollment In SAMBA Femoropopliteal Trial
16:07NanoViricides Signs Master Service Agreement With Southern Research Institute

Source: Forbes.com
 Published on: 2010-09-01
16:00Allscripts CEO On New Merger

 Published on: 2010-08-31
12:00America's Most Profitable Hospitals

 Published on: 2010-08-30
20:00San Francisco's Penthouse Palace

 Published on: 2010-08-26
20:00Relative Learning: Where Do We Stand?
20:00Is Tenure A Privilege Or Right?
12:00HCA Buyout May Pay Off Big

 Published on: 2010-08-25
16:00M&A: Creative Private Equity Deals

 Published on: 2010-08-23
08:00Top Back-To-School Health Tips

 Published on: 2010-08-20
16:00James Patterson, Top-Earning Author

 Published on: 2010-08-18
20:00Hip-Hop's Newest Star

 Published on: 2010-08-17
20:00Growing Pfizer
20:00Poop To Profits
20:00How To Survive Beyond A Lifetime
20:00Upsizing In A Downturn
12:00Russell Simmons On 2010 Cash Kings

 Published on: 2010-08-12
16:00Expendables Star Talks Success

 Published on: 2010-08-11
20:00Hopkins' New Business School
20:00Doctors In Paradise
20:00Ken Burns' Next Hit
20:00Harvard's Social And Final Club Scene
20:00Golfer Phil Mickelson: Math Master

 Published on: 2010-08-09
08:00July's Biotech Busts And Breakthroughs

 Published on: 2010-08-03
16:00SPX's Christopher Kearney
16:00Geithner Says Banks Should Act Now

 Published on: 2010-07-29
20:00Industries Looking To Hire You Now



Home    •    Career Fair Schedule    •    View Services    •    Terms of Use    •    Advertise With Us    •    Post Jobs    •    Career Resources    •    ST in the Community
Subscribe to our E-zine    •    About SalesTrax    •    Submit Articles    •    Link to Us    •    Ad Agencies    •    Contact Us    •    Privacy Policy    •    Site Map
©2010 - SalesTrax, LLC - All Rights Reserved.